Summary:
The purpose of this study is to compare the efficacy of BHV-4157 versus placebo in subjects with Obsessive Compulsive Disorder (OCD).
Qualified Participants Must:
Be between 18 and 65 years old
Have OCD for at least 1 year
Qualified Participants May Receive:
If qualified participants will receive compensation for time and travel